CCM
VIVO

Cadence Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Cadence Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$560K Buy
+33,000
New +$641K 0.14% 123
2019
Q2 		– Sell
-76,464
Closed -$1.35M – 465
2019
Q1 		$1.35M Buy
+76,464
New +$1.27M 0.12% 231

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cadence Capital Management's VIVO Position: Q3 2020 in Review

Cadence Capital Management opened a new position in Meridian Bioscience Inc (VIVO) in Q3 2020: 33,000 shares worth $560K. The stake represents 0.14% of the portfolio and ranks #123 among its holdings. This is a return to the name: Cadence Capital Management previously reported a position in VIVO as recently as Q1 2019.

Cadence Capital Management first reported a position in VIVO in Q1 2019 and has held it in 2 quarters since. The position peaked at $1.35M in Q1 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Cadence Capital Management held 33,000 shares of Meridian Bioscience Inc worth $560K as of Q3 2020.
  • Meridian Bioscience Inc was a new Cadence Capital Management position in Q3 2020.
  • Meridian Bioscience Inc made up 0.14% of Cadence Capital Management's portfolio in Q3 2020, its #123 holding.
  • Cadence Capital Management first reported a position in Meridian Bioscience Inc in Q1 2019 and has held it in 2 quarters since.
  • Cadence Capital Management's Meridian Bioscience Inc position peaked at $1.35M in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.